LTA and neoplasm: In the Northern Hemisphere, the majority of MCCs is associated with MCPyV, including the US (~80%), Europe (~70–85%), and Japan (~90%), and the expression of the viral oncogenes LT- and sT-antigen in tumor cells can regularly be observed.